CAS 2701758-99-6

Methyl 5-chloro-2-ethoxy-4-nitrobenzoate

Codes: Mosapride Citrate-072

Application context (from source-drug indications)

GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Mosapride Citrate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Mosapride CitrateOptimised routesteps: 6total yield: 54.6g(Mosapride Citrate (API))

2-Fluoro-4-nitrobenzenecarboxylic acid→Methyl 2-fluoro-4-nitrobenzenecarboxylate→Ethanol sodium salt→Methyl 2-ethoxy-4-nitrobenzoate→Methyl 5-chloro-2-ethoxy-4-nitrobenzoate→[4-(4-Fluorobenzyl)-2-morpholinyl]methylamine→Mosapride Citrate-007

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.